Cargando…
Novel developments in angiogenesis cancer therapy
A greater understanding of the factors and pathways controlling angiogenesis in tumours has allowed the development of a number of agents that selectively inhibit the pathways mediating that activity. The results to date of clinical trials with such agents and future research opportunities are revie...
Autor principal: | Hirte, H.W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695705/ https://www.ncbi.nlm.nih.gov/pubmed/19526086 |
Ejemplares similares
-
Development of cell-cycle inhibitors for cancer therapy
por: Dickson, M.A., et al.
Publicado: (2009) -
rna interference and micro rna –oriented therapy in cancer: rationales, promises, and challenges
por: Duchaine, T.F., et al.
Publicado: (2009) -
Histone deacetylase inhibitors as novel anticancer therapeutics
por: Walkinshaw, D.R., et al.
Publicado: (2008) -
Small-molecule Bcl-2 antagonists as targeted therapy in oncology
por: Warr, M.R., et al.
Publicado: (2008) -
Microrna let-7: an emerging next-generation cancer therapeutic
por: Barh, D., et al.
Publicado: (2010)